SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 22, 2004
CORAUTUS GENETICS INC.
(ExactNameOfRegistrant As Specified In Charter)
| | | | |
| Delaware | | 0-27264 | | 33-0687976 |
(State of Incorporation) | | (Commission File No.) | | (I.R.S. Employer Identification No.) |
75 Fifth Street, Suite 313
Atlanta, Georgia 30308
(Address of principal executive offices, including zip code)
(404) 526-6200
(Registrant’s telephone number, including area code)
Item 5. Other Events.
On July 26, 2004, Corautus Genetics Inc. issued a press release, attached hereto as Exhibit 99.1, announcing that it had closed on $5,000,000 of the $15,000,000 convertible debt facility made available to the company by Boston Scientific Corporation under a loan agreement, as amended, established between the companies in July 2003.
Item 7. Financial Statements and Exhibits
(c)
| | |
Exhibit Number
| | Description
|
| 99.1 | | Press Release dated July 26, 2004. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| | | Corautus Genetics Inc. |
| | |
| Date: July 26, 2004 | | By: | | /s/ Jack W. Callicutt
|
| | | | | Jack W. Callicutt |
| | | | | Vice President - Finance and Administration, |
| | | | | Chief Accounting Officer and Assistant Secretary |
